Correlation Between Codexis and OnKure Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Codexis and OnKure Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Codexis and OnKure Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Codexis and OnKure Therapeutics,, you can compare the effects of market volatilities on Codexis and OnKure Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Codexis with a short position of OnKure Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Codexis and OnKure Therapeutics,.

Diversification Opportunities for Codexis and OnKure Therapeutics,

0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Codexis and OnKure is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Codexis and OnKure Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OnKure Therapeutics, and Codexis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Codexis are associated (or correlated) with OnKure Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OnKure Therapeutics, has no effect on the direction of Codexis i.e., Codexis and OnKure Therapeutics, go up and down completely randomly.

Pair Corralation between Codexis and OnKure Therapeutics,

Given the investment horizon of 90 days Codexis is expected to generate 1.08 times more return on investment than OnKure Therapeutics,. However, Codexis is 1.08 times more volatile than OnKure Therapeutics,. It trades about -0.18 of its potential returns per unit of risk. OnKure Therapeutics, is currently generating about -0.23 per unit of risk. If you would invest  467.00  in Codexis on November 30, 2024 and sell it today you would lose (163.00) from holding Codexis or give up 34.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Codexis  vs.  OnKure Therapeutics,

 Performance 
       Timeline  
Codexis 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Codexis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
OnKure Therapeutics, 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days OnKure Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Codexis and OnKure Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Codexis and OnKure Therapeutics,

The main advantage of trading using opposite Codexis and OnKure Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Codexis position performs unexpectedly, OnKure Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will offset losses from the drop in OnKure Therapeutics,'s long position.
The idea behind Codexis and OnKure Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Transaction History
View history of all your transactions and understand their impact on performance
Bonds Directory
Find actively traded corporate debentures issued by US companies